If you are in the healthcare or pharmaceutical industry, you may qualify to receive a complimentary Market Overview of our completed NetNog: #genesis® research.
NetNog: #genesis® Cystic Fibrosis is offered as a syndicated market research report. As of July 2020, NetNoggin® has updated NetNog: #genesis® Cystic Fibrosis to reflect changes due to TRIKAFTA.
NetNog: #genesis® NASH (including NAFL) is offered as a syndicated market research report and is available!
NetNog: #genesis® helps align clinical trial design with your commercialization strategy so you have a higher ROI for your product. We contextualize consumer experiences by moving beyond the algorithm. NetNog: #genesis® delivers syndicated, ethnographic-quality research, which includes elements of NetNog: #buy® and NetNog: #talk®. NetNog: #genesis® research reports include:
The executive summary highlights key findings, multi-media representations of the patient, and common lexicon associated with the condition.
Market overview critically reviews epidemiology, pathophysiology, and a patient journey as defined by guidelines.
Digital dashboard offers a summation of the digital landscape by analyzing conversation volumes by social channels and top posters.
Using netnographic methodologies, NetNoggin® reports on patient and caregiver expressed journeys, outcomes, emotions, HCP interactions, resources, and more!
The implications section compares what should be happening (guidelines) in the market to patients/caregivers perspectives, as well as patient-expressed unmet needs.
After the purchase of NetNog: #genesis® research, NetNoggin® creates a customized presentation tailored to the needs and pain points of that specific company.